New generation of dendritic cell vaccines

Kristen J Radford, Irina Caminschi

Research output: Contribution to journalReview ArticleOtherpeer-review

23 Citations (Scopus)

Abstract

Dendritic cells (DC) play a pivotal role in the induction and regulation of immune responses, including the induction of cytotoxic T lymphocytes (CTL) responses. These are essential for the eradication of cancers and pathogens including HIV and malaria, for which there are currently no effective vaccines. New developments in our understanding of DC biology have identified the key DC subset responsible for CTL induction, which is now an attractive candidate to target for vaccination. These DC are characterized by expression of novel markers Clec9A and XCR1, and a specialized capacity to cross-present antigen (Ag) from tumors and pathogens that do not directly infect DC. New generation DC vaccines that specifically target the cross-presenting DC in vivo have already demonstrated potential in preclinical animal models but the challenge remains to translate these findings into clinically efficacous vaccines in man. This has been greatly facilitated by the recent identification of the equivalent Clec9A+XCR1+ cross-presenting DC in human lymphoid tissues and peripheral tissues that are key sites for vaccination administration. These findings combined with further studies on DC subset biology have important implications for the design of new CTL-mediated vaccines.

Original languageEnglish
Pages (from-to)259-264
Number of pages6
JournalHuman Vaccines & Immunotherapeutics
Volume9
Issue number2
DOIs
Publication statusPublished - 2013
Externally publishedYes

Keywords

  • Cytotoxic T cells
  • Dendritic cells
  • Targeting
  • Tumor immunity
  • Vaccines

Cite this

Radford, Kristen J ; Caminschi, Irina. / New generation of dendritic cell vaccines. In: Human Vaccines & Immunotherapeutics. 2013 ; Vol. 9, No. 2. pp. 259-264.
@article{4a3351779c19434e8afb4dd546281ebb,
title = "New generation of dendritic cell vaccines",
abstract = "Dendritic cells (DC) play a pivotal role in the induction and regulation of immune responses, including the induction of cytotoxic T lymphocytes (CTL) responses. These are essential for the eradication of cancers and pathogens including HIV and malaria, for which there are currently no effective vaccines. New developments in our understanding of DC biology have identified the key DC subset responsible for CTL induction, which is now an attractive candidate to target for vaccination. These DC are characterized by expression of novel markers Clec9A and XCR1, and a specialized capacity to cross-present antigen (Ag) from tumors and pathogens that do not directly infect DC. New generation DC vaccines that specifically target the cross-presenting DC in vivo have already demonstrated potential in preclinical animal models but the challenge remains to translate these findings into clinically efficacous vaccines in man. This has been greatly facilitated by the recent identification of the equivalent Clec9A+XCR1+ cross-presenting DC in human lymphoid tissues and peripheral tissues that are key sites for vaccination administration. These findings combined with further studies on DC subset biology have important implications for the design of new CTL-mediated vaccines.",
keywords = "Cytotoxic T cells, Dendritic cells, Targeting, Tumor immunity, Vaccines",
author = "Radford, {Kristen J} and Irina Caminschi",
year = "2013",
doi = "10.4161/hv.22487",
language = "English",
volume = "9",
pages = "259--264",
journal = "Human Vaccines & Immunotherapeutics",
issn = "2164-5515",
publisher = "Taylor & Francis",
number = "2",

}

New generation of dendritic cell vaccines. / Radford, Kristen J; Caminschi, Irina.

In: Human Vaccines & Immunotherapeutics, Vol. 9, No. 2, 2013, p. 259-264.

Research output: Contribution to journalReview ArticleOtherpeer-review

TY - JOUR

T1 - New generation of dendritic cell vaccines

AU - Radford, Kristen J

AU - Caminschi, Irina

PY - 2013

Y1 - 2013

N2 - Dendritic cells (DC) play a pivotal role in the induction and regulation of immune responses, including the induction of cytotoxic T lymphocytes (CTL) responses. These are essential for the eradication of cancers and pathogens including HIV and malaria, for which there are currently no effective vaccines. New developments in our understanding of DC biology have identified the key DC subset responsible for CTL induction, which is now an attractive candidate to target for vaccination. These DC are characterized by expression of novel markers Clec9A and XCR1, and a specialized capacity to cross-present antigen (Ag) from tumors and pathogens that do not directly infect DC. New generation DC vaccines that specifically target the cross-presenting DC in vivo have already demonstrated potential in preclinical animal models but the challenge remains to translate these findings into clinically efficacous vaccines in man. This has been greatly facilitated by the recent identification of the equivalent Clec9A+XCR1+ cross-presenting DC in human lymphoid tissues and peripheral tissues that are key sites for vaccination administration. These findings combined with further studies on DC subset biology have important implications for the design of new CTL-mediated vaccines.

AB - Dendritic cells (DC) play a pivotal role in the induction and regulation of immune responses, including the induction of cytotoxic T lymphocytes (CTL) responses. These are essential for the eradication of cancers and pathogens including HIV and malaria, for which there are currently no effective vaccines. New developments in our understanding of DC biology have identified the key DC subset responsible for CTL induction, which is now an attractive candidate to target for vaccination. These DC are characterized by expression of novel markers Clec9A and XCR1, and a specialized capacity to cross-present antigen (Ag) from tumors and pathogens that do not directly infect DC. New generation DC vaccines that specifically target the cross-presenting DC in vivo have already demonstrated potential in preclinical animal models but the challenge remains to translate these findings into clinically efficacous vaccines in man. This has been greatly facilitated by the recent identification of the equivalent Clec9A+XCR1+ cross-presenting DC in human lymphoid tissues and peripheral tissues that are key sites for vaccination administration. These findings combined with further studies on DC subset biology have important implications for the design of new CTL-mediated vaccines.

KW - Cytotoxic T cells

KW - Dendritic cells

KW - Targeting

KW - Tumor immunity

KW - Vaccines

UR - http://www.scopus.com/inward/record.url?scp=84874674906&partnerID=8YFLogxK

U2 - 10.4161/hv.22487

DO - 10.4161/hv.22487

M3 - Review Article

AN - SCOPUS:84874674906

VL - 9

SP - 259

EP - 264

JO - Human Vaccines & Immunotherapeutics

JF - Human Vaccines & Immunotherapeutics

SN - 2164-5515

IS - 2

ER -